<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>starboardtack</title><link>https://investorshangout.com/profile/view?id=40609</link><description><![CDATA[starboardtack]]></description><language>en-us</language><pubDate>Thu, 01 Oct 2026 05:28:42 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/profile/view?id=40609" rel="self" type="application/rss+xml"/><item><title>starboardtack: Keep reading me on IHub. Use your imagination</title><link>https://investorshangout.com/post/view?id=4633050</link><guid>https://investorshangout.com/post/view?id=4633050</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 23:18:15 GMT</pubDate></item><item><title>starboardtack: &quot;We all know&quot; . . . Most of the posts seem to be</title><link>https://investorshangout.com/post/view?id=4632876</link><guid>https://investorshangout.com/post/view?id=4632876</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 20:28:52 GMT</pubDate></item><item><title>starboardtack: Do you actually read the post. I stated that the</title><link>https://investorshangout.com/post/view?id=4632855</link><guid>https://investorshangout.com/post/view?id=4632855</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 20:00:50 GMT</pubDate></item><item><title>starboardtack: If you are directing your post to me. . . None of</title><link>https://investorshangout.com/post/view?id=4632809</link><guid>https://investorshangout.com/post/view?id=4632809</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 19:43:54 GMT</pubDate></item><item><title>starboardtack: Never on IHub. Read it once years ago but never</title><link>https://investorshangout.com/post/view?id=4632645</link><guid>https://investorshangout.com/post/view?id=4632645</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 18:31:53 GMT</pubDate></item><item><title>starboardtack: Please revisit my last post as I clearly made the</title><link>https://investorshangout.com/post/view?id=4632552</link><guid>https://investorshangout.com/post/view?id=4632552</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 17:48:43 GMT</pubDate></item><item><title>starboardtack: The trials they are pursuing first are the</title><link>https://investorshangout.com/post/view?id=4632504</link><guid>https://investorshangout.com/post/view?id=4632504</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 17:23:05 GMT</pubDate></item><item><title>starboardtack: This is great. You are criticizing me for using</title><link>https://investorshangout.com/post/view?id=4632393</link><guid>https://investorshangout.com/post/view?id=4632393</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 16:38:32 GMT</pubDate></item><item><title>starboardtack: It appears their cash flow burn rate can be held</title><link>https://investorshangout.com/post/view?id=4631629</link><guid>https://investorshangout.com/post/view?id=4631629</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 14:35:05 GMT</pubDate></item><item><title>starboardtack: Trying to be objective, acknowledging adverse</title><link>https://investorshangout.com/post/view?id=4630538</link><guid>https://investorshangout.com/post/view?id=4630538</guid><description><![CDATA[starboardtack
]]></description><pubDate>Thu, 29 Jun 2017 00:31:25 GMT</pubDate></item><item><title>starboardtack: As a speculative bio play, this is one of the</title><link>https://investorshangout.com/post/view?id=4630162</link><guid>https://investorshangout.com/post/view?id=4630162</guid><description><![CDATA[starboardtack
]]></description><pubDate>Wed, 28 Jun 2017 18:55:46 GMT</pubDate></item><item><title>starboardtack: Do not disagree. My point is that they are</title><link>https://investorshangout.com/post/view?id=4614246</link><guid>https://investorshangout.com/post/view?id=4614246</guid><description><![CDATA[starboardtack
]]></description><pubDate>Tue, 20 Jun 2017 00:12:38 GMT</pubDate></item><item><title>starboardtack: Note that Baxdela was approved by the FDA today</title><link>https://investorshangout.com/post/view?id=4614134</link><guid>https://investorshangout.com/post/view?id=4614134</guid><description><![CDATA[starboardtack
]]></description><pubDate>Mon, 19 Jun 2017 21:04:00 GMT</pubDate></item><item><title>starboardtack: B-OM is the likelier candidate for a similar</title><link>https://investorshangout.com/post/view?id=4581390</link><guid>https://investorshangout.com/post/view?id=4581390</guid><description><![CDATA[starboardtack
]]></description><pubDate>Wed, 31 May 2017 16:55:19 GMT</pubDate></item><item><title>starboardtack: Exactly. If Leo et. al. went with a B p3</title><link>https://investorshangout.com/post/view?id=4436656</link><guid>https://investorshangout.com/post/view?id=4436656</guid><description><![CDATA[starboardtack
]]></description><pubDate>Fri, 24 Mar 2017 15:18:17 GMT</pubDate></item><item><title>starboardtack: If you are referring to the OM trial. . .the</title><link>https://investorshangout.com/post/view?id=4435982</link><guid>https://investorshangout.com/post/view?id=4435982</guid><description><![CDATA[starboardtack
]]></description><pubDate>Fri, 24 Mar 2017 13:35:35 GMT</pubDate></item></channel></rss>